rs267606835
Positions:
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BS2_Supporting
The NM_001360016.2(G6PD):c.317C>T(p.Ser106Phe) variant causes a missense change. The variant allele was found at a frequency of 0.0000116 in 1,210,741 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000012 ( 0 hom. 4 hem. )
Consequence
G6PD
NM_001360016.2 missense
NM_001360016.2 missense
Scores
5
5
7
Clinical Significance
Conservation
PhyloP100: 6.22
Genes affected
G6PD (HGNC:4057): (glucose-6-phosphate dehydrogenase) This gene encodes glucose-6-phosphate dehydrogenase. This protein is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions. G6PD is remarkable for its genetic diversity. Many variants of G6PD, mostly produced from missense mutations, have been described with wide ranging levels of enzyme activity and associated clinical symptoms. G6PD deficiency may cause neonatal jaundice, acute hemolysis, or severe chronic non-spherocytic hemolytic anemia. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -1 ACMG points.
BS2
High Hemizygotes in GnomAdExome4 at 4 XL geneVariant has number of hemizygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
G6PD | NM_001360016.2 | c.317C>T | p.Ser106Phe | missense_variant | 5/13 | ENST00000393562.10 | NP_001346945.1 | |
G6PD | NM_000402.4 | c.407C>T | p.Ser136Phe | missense_variant | 5/13 | NP_000393.4 | ||
G6PD | NM_001042351.3 | c.317C>T | p.Ser106Phe | missense_variant | 5/13 | NP_001035810.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
G6PD | ENST00000393562.10 | c.317C>T | p.Ser106Phe | missense_variant | 5/13 | 1 | NM_001360016.2 | ENSP00000377192.3 |
Frequencies
GnomAD3 genomes AF: 0.00000888 AC: 1AN: 112559Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34685
GnomAD3 genomes
AF:
AC:
1
AN:
112559
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34685
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 182935Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67507
GnomAD3 exomes
AF:
AC:
2
AN:
182935
Hom.:
AF XY:
AC XY:
1
AN XY:
67507
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000118 AC: 13AN: 1098182Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 4AN XY: 363538
GnomAD4 exome
AF:
AC:
13
AN:
1098182
Hom.:
Cov.:
31
AF XY:
AC XY:
4
AN XY:
363538
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000888 AC: 1AN: 112559Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34685
GnomAD4 genome
AF:
AC:
1
AN:
112559
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34685
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ExAC
AF:
AC:
2
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Anemia, nonspherocytic hemolytic, due to G6PD deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 03, 2022 | This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 106 of the G6PD protein (p.Ser106Phe). This variant is present in population databases (rs267606835, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with G6PD-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt G6PD protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Benign
DEOGEN2
Pathogenic
D;D;D;.;D;.;D
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;.;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Benign
N;N;N;N;.;.;.
PrimateAI
Uncertain
T
PROVEAN
Benign
.;.;N;N;N;N;N
REVEL
Pathogenic
Sift
Benign
.;.;T;T;T;T;T
Sift4G
Benign
T;.;T;T;.;.;.
Polyphen
B;B;B;.;.;.;.
Vest4
MutPred
Loss of disorder (P = 0.0568);Loss of disorder (P = 0.0568);Loss of disorder (P = 0.0568);Loss of disorder (P = 0.0568);Loss of disorder (P = 0.0568);Loss of disorder (P = 0.0568);Loss of disorder (P = 0.0568);
MVP
MPC
0.29
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at